These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3314066)

  • 21. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
    Parekh DJ; Cookson MS; Chapman W; Harrell F; Wells N; Chang SS; Smith JA
    J Urol; 2005 Jun; 173(6):1897-902. PubMed ID: 15879771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma: a stratification tool for prospective clinical trials.
    Leibovich BC; Han KR; Bui MH; Pantuck AJ; Dorey FJ; Figlin RA; Belldegrun A
    Cancer; 2003 Dec; 98(12):2566-75. PubMed ID: 14669275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of isolated renal fossa recurrence following radical nephrectomy.
    Master VA; Gottschalk AR; Kane C; Carroll PR
    J Urol; 2005 Aug; 174(2):473-7; discussion 477. PubMed ID: 16006867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection.
    Pantuck AJ; Zisman A; Dorey F; Chao DH; Han KR; Said J; Gitlitz BJ; Figlin RA; Belldegrun AS
    J Urol; 2003 Jun; 169(6):2076-83. PubMed ID: 12771723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognostic factors for predicting the success of immunotherapy in metastatic renal cell carcinoma].
    Schmitz-Dräger BJ; Jankevicius F; Otto T
    Urologe A; 1995 May; 34(3):195-9. PubMed ID: 7610511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas.
    Klatte T; Patard JJ; de Martino M; Bensalah K; Verhoest G; de la Taille A; Abbou CC; Allhoff EP; Carrieri G; Riggs SB; Kabbinavar FF; Belldegrun AS; Pantuck AJ
    J Urol; 2008 May; 179(5):1719-26. PubMed ID: 18343437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Debulking nephrectomy in metastatic renal cancer.
    Flanigan RC
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6335S-41S. PubMed ID: 15448027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EORTC-GU group expert opinion on metastatic renal cell cancer.
    de Reijke TM; Bellmunt J; van Poppel H; Marreaud S; Aapro M
    Eur J Cancer; 2009 Mar; 45(5):765-73. PubMed ID: 19157861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nephrectomy for metastatic renal cell carcinoma and surgery for distant metastases.
    Van Poppel H; Baert L
    Acta Urol Belg; 1996 May; 64(2):11-7. PubMed ID: 8701800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal cell carcinoma: presentation, staging, and surgical treatment.
    Russo P
    Semin Oncol; 2000 Apr; 27(2):160-76. PubMed ID: 10768595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of surgery in metastatic renal cell carcinoma.
    Flanigan RC
    Semin Urol; 1989 Aug; 7(3):191-4. PubMed ID: 2481332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of relapse and response to retreatment in patients with metastatic melanoma or renal cell carcinoma who responded to interleukin-2-based immunotherapy.
    Lee DS; White DE; Hurst R; Rosenberg SA; Yang JC
    Cancer J Sci Am; 1998; 4(2):86-93. PubMed ID: 9532410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of metastatic renal cell carcinoma: current trends.
    Mohammed A; Shergill I; Little B
    Expert Rev Mol Diagn; 2009 Jan; 9(1):75-83. PubMed ID: 19099350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of distant solitary recurrence in the patient with renal cancer. Contralateral kidney and other sites.
    Kozlowski JM
    Urol Clin North Am; 1994 Nov; 21(4):601-24. PubMed ID: 7974893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytoreductive nephrectomy for T4NxM1 renal cell carcinoma: the M.D. Anderson Cancer Center experience.
    Kassouf W; Sanchez-Ortiz R; Tamboli P; Jonasch E; Merchant MM; Spiess PE; Wood CG
    Urology; 2007 May; 69(5):835-8. PubMed ID: 17482917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
    Blute ML; Itano NB; Cheville JC; Weaver AL; Lohse CM; Zincke H
    J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single center preliminary experience with hand-assisted laparoscopic resection of isolated renal cell carcinoma fossa recurrences.
    Bandi G; Wen CC; Moon TD; Nakada SY
    Urology; 2008 Mar; 71(3):495-9; discussion 499-500. PubMed ID: 18342195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Improvement in the prognosis of renal cell carcinoma by percutaneous transvascular embolization].
    Stösslein F; Schwenke A; Münster W; Köhler H; Mebel M; Raatzsch H; Steude U; Krosegk G
    Z Urol Nephrol; 1987 Oct; 80(10):577-86. PubMed ID: 3433986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metastasectomy without systemic therapy in metastatic renal cell carcinoma: comparison with conservative treatment.
    Kwak C; Park YH; Jeong CW; Lee SE; Ku JH
    Urol Int; 2007; 79(2):145-51. PubMed ID: 17851285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.